The first American College of Nurse-Midwives Women’s Health Expo will be held May 24, 2008, in Boston in conjunction with the ACNM 53rd Annual Meeting & Exposition. The consumer-focused Expo will include an interactive women’s health experience promoted through the local and regional media and medical community partnerships. More than 2,000 nurse-midwives, physicians, nurses, and other women’s health care professionals from the U. [click link for full article]

Community-acquired pneumonia (CAP) is frequently a severe illness and is the leading cause of death by infectious disease and the sixth leading cause of global mortality in the first world. For this reason, improving the care of adult patients with CAP is one of the focuses of the most important research worldwide. [click link for full article]

Resistance to the antibiotics that specifically target the tuberculosis (TB) bacillus is a severe challenge in developing countries, yet seems relatively uncommon among subjects born in France who have not previously been treated for TB. So concludes an important study by Jérôme Robert and his team (Université Pierre et Marie Curie-Paris 6, Laboratoire de Bactériologie-Hygiène) in the forthcoming issue of the European Respiratory Journal (ERJ). [click link for full article]

IntraOp Medical Corporation (OTCBB: IOPM), a provider of innovative technology solutions for the treatment and eradication of cancer, announced today that it received an order to deliver one Mobetron to Centro di Riferimento Oncologico (CRO) in Aviano, Italy. CRO is the fourth Italian hospital to have a Mobetron and the 23rd Mobetron ordered worldwide. [click link for full article]

About 4% of patients with persistent symptoms after pulmonary embolism develop hypertension in the pulmonary circulation, also called pulmonary hypertension. This is a serious complication leading to disabling symptoms, impaired exercise capacity and increased mortality if left untreated. Some patients might be cured by surgery, but in those not eligible for surgery medical therapy is warranted but not thus far established. [click link for full article]

Health officials from New York city confirmed yesterday that a seventh grade male student who died on the 14th of October had MRSA, a highly infectious drug resistant form of staph bacteria that normally occurs in hospitals and nursing homes but is now beginning to take hold in community based places such as sports centres, schools and gyms. It has become known as CA-MRSA, or community-acquired MRSA. [click link for full article]

About 77% of young people in Thailand have limited knowledge about HIV/AIDS, the Ministry of Public Health said recently, TNA/MCOT News reports. A surveillance report released last month found that about 321,650 people in the country are living with HIV/AIDS and that half of them are between ages 25 and 34. [click link for full article]

Yale School of Medicine researchers have received $8.4 million to study how cancer cells mend their own chromosomes and DNA after damage caused by radiation and chemotherapy.The study funded by the National Institutes of Health (NIH) is the next step in developing targeted cancer therapies, said the lead researcher, Peter Glazer, M.D., chair of therapeutic radiology and leader of the radiobiology research program at Yale Cancer Center. [click link for full article]

Individuals contemplating computed tomographic (CT) screening for lung cancer because they are concerned that they are at risk should talk to their physicians. In this discussion, information on the benefit of the screening for that particular person, based on their age and smoking history, needs to be available to the person and the consulting physician. [click link for full article]

A Canadian trial involving the antifibrinolytic drug Trasylol (aprotinin), used to control bleeding in high risk heart surgery patients has been halted. Trial patients on Trasylol (aprotinin), made by German-based drug company Bayer, appeared to be at a higher risk of death compared to patients treated with the other two antifibrinolytic drugs, aminocaproic acid and tranexamic acid. The patients were having a repeat bypass operation or having one or more valves replaced. [click link for full article]